Inflation type one error: FDA [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-10 11:33 (443 d 21:10 ago) – Posting: # 20780
Views: 1,745

Hi Mikalai,

» […] what regulators say on this subject? I do not remember any reflection on this matter in official documents (EMA, FDA)?

Some slides of Terry Hyslop (Director, Division of Biostatistics) of his presentation “Bioequivalence (BE) for Highly Variable Drugs” at the AAPS Workshop (New Orleans, Nov 2010) – after the progesterone guidance was published…


[image]

[image]
Aka the ‘implied limits’ (see this post and slide 23 below).

[image]

[image]
Well roared, lion! Trouble starts because we use \(s_{WR}\) instead of the unknown \(\sigma_{WR}\).
Nasty but \(s_{WR}\) is all we have.
Typo, should read
… use scaled average BE if sWR > cutoff.

[image]

[image]
Illegible text (white with grey shadowing):
  assuming no subject-by-formulation interaction, σWT = σWR,
  true GMR = max (1.25, implied scaled BE limit)

[image]

[image]


Check:

library(PowerTOST)
res        <- data.frame(method = c("ABE", "RSABE"), TIE = NA)
res$TIE[1] <- power.TOST(CV = 0.3, n = 36, theta0 = 1.25,
                         design ="2x3x3")
res$TIE[2] <- power.RSABE(CV = 0.3, n = 36, theta0 = 1.25,
                          design ="2x3x3", nsims = 1e6)
res$TIE    <- signif(res$TIE, 4)
print(res, row.names = FALSE)

# method    TIE
#    ABE
0.0500
#  RSABE 0.1323


Hence, the FDA was well aware of the inflated type I error and decided to ignore it.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,316 posts in 4,446 threads, 1,489 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Wednesday 08:43 CET (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5